High angiopoietin-2 and suppression of tumorigenicity-2 levels correlate with onset of sinusoidal obstructive syndrome-implication for the utility of serial biomarker monitoring
- PMID: 28287645
- PMCID: PMC8171580
- DOI: 10.1038/bmt.2017.38
High angiopoietin-2 and suppression of tumorigenicity-2 levels correlate with onset of sinusoidal obstructive syndrome-implication for the utility of serial biomarker monitoring
Conflict of interest statement
CONFLICT OF INTEREST
The authors declare no conflict of interest.
Figures


Similar articles
-
Sinusoidal obstructive syndrome prophylaxis with recombinant human soluble thrombomodulin is feasible in gemtuzumab ozogamicin-treated patients undergoing allogeneic hematopoietic cell transplantation.Bone Marrow Transplant. 2017 Jul;52(7):1068-1070. doi: 10.1038/bmt.2017.65. Epub 2017 Apr 3. Bone Marrow Transplant. 2017. PMID: 28368378 No abstract available.
-
Hepatic sinusoidal obstruction syndrome following hematopoietic stem cell transplantation.Oncol Nurs Forum. 2008 Jan;35(1):37-9. doi: 10.1188/08.ONF.37-40. Oncol Nurs Forum. 2008. PMID: 18192151 Review. No abstract available.
-
Ultrasound elastography techniques for diagnosis and follow-up of hepatic veno-occlusive disease.Bone Marrow Transplant. 2019 Jul;54(7):1145-1147. doi: 10.1038/s41409-019-0432-5. Epub 2019 Jan 24. Bone Marrow Transplant. 2019. PMID: 30679827 Free PMC article. No abstract available.
-
Soluble PD-1 and PD-L1 as potential biomarkers for classical Hodgkin lymphoma.Hematol Oncol. 2018 Oct;36(4):709-712. doi: 10.1002/hon.2542. Epub 2018 Aug 26. Hematol Oncol. 2018. PMID: 30146693 Clinical Trial. No abstract available.
-
Recognize hepatic sinusoidal obstruction syndrome in patients with cancer.ONS Connect. 2008 Mar;23(3):22-3. ONS Connect. 2008. PMID: 18432087 Review. No abstract available.
References
-
- Kennedy-Nasser AA, Ku S, Castillo-Caro P, Hazrat Y, Wu MF, Liu H et al. Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activity. Clin Cancer Res 2014; 20: 2215–2225. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical